Fate of a Burkholderia pseudomallei mouse macrophage cell line lipopolysaccharide mutant in the RAW 264.7:: Possible role for the o-antigenic polysaccharide moiety of lipopolysaccharide in internalization and intracellular survival

被引:50
作者
Arjcharoen, S. [1 ]
Wikraiphat, C. [1 ]
Pudla, M. [1 ]
Limposuwan, K. [1 ]
Woods, D. E. [1 ]
Sirisinha, S. [1 ]
Utaisincharoen, P. [1 ]
机构
[1] Mahidol Univ, Fac Sci, Dept Microbiol, Bangkok 10400, Thailand
关键词
D O I
10.1128/IAI.00285-07
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Burkholderia pseudomallei is a facultative intracellular gram-negative bacterium that can survive and multiply inside macrophages. One of the mechanisms by which B. pseudomallei escapes macrophage killing is by interfering with the expression of inducible nitric oxide synthase (iNOS). However, the bacterial components that modulate antimicrobial activity of the macrophage have not been fully elucidated. In the present study, we demonstrated that B. pseudomallei strain SRM117, a lipopolysaccharide (LPS) mutant that lacks the O-antigenic polysaccharide moiety, was more susceptible to macrophage killing during the early phase of infection than the parental wild-type strain (1026b). Unlike the wild type, the LPS mutant could readily stimulate Y701-STAT-1 phosphorylation (pY701-STAT-1) and interferon-regulatory factor 1 (IRF-1) expression, both of which are essential transcription factors of iNOS. Neutralizing antibody against beta interferon was able to inhibit the phosphorylation of Y701-STAT-1 and the expression of IRF-1 and iNOS, all of which resulted in an increased rate of intracellular replication. These data suggest that the O-antigenic polysaccharide moiety of B. pseudomallei modulates the host cell response, which in turn controls the intracellular fate of B. pseudomallei inside macrophages.
引用
收藏
页码:4298 / 4304
页数:7
相关论文
共 34 条
[1]   Lipopolysaccharide from nonvirulent Ara+ Burkholderia pseudomallei isolates is immunologically indistinguishable from lipopolysaccharide from virulent Ara- clinical isolates [J].
Anuntagool, N ;
Intachote, P ;
Wuthiekanun, V ;
White, NJ ;
Sirisinha, S .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1998, 5 (02) :225-229
[2]   Antigenic relatedness between Burkholderia pseudomallei and Burkholderia mallei [J].
Anuntagool, N ;
Sirisinha, S .
MICROBIOLOGY AND IMMUNOLOGY, 2002, 46 (03) :143-150
[3]   A mutant of Burkholderia pseudomallei, auxotrophic in the branched chain amino acid biosynthetic pathway, is attenuated and protective in a murine model of melioidosis [J].
Atkins, T ;
Prior, RG ;
Mack, K ;
Russell, P ;
Nelson, M ;
Oyston, PCF ;
Dougan, G ;
Titball, RW .
INFECTION AND IMMUNITY, 2002, 70 (09) :5290-5294
[4]   Presence or absence of lipopolysaccharide o antigens affects type III secretion by Pseudomonas aeruginosa [J].
Augustin, D. K. ;
Song, Y. ;
Baek, M. S. ;
Sawa, Y. ;
Singh, G. ;
Taylor, B. ;
Rubio-Mills, A. ;
Flanagan, J. L. ;
Wiener-Kronish, J. P. ;
Lynch, S. V. .
JOURNAL OF BACTERIOLOGY, 2007, 189 (06) :2203-2209
[5]   Role of inducible nitric oxide synthase and NADPH oxidase in early control of Burkholderia pseudomallei infection in mice [J].
Breitbach, Katrin ;
Klocke, Sonja ;
Tschernig, Thomas ;
van Rooijen, Nico ;
Baumann, Ulrich ;
Steinmetz, Ivo .
INFECTION AND IMMUNITY, 2006, 74 (11) :6300-6309
[6]   ISOLATION AND CHARACTERIZATION OF PSEUDOMONAS-PSEUDOMALLEI FLAGELLIN PROTEINS [J].
BRETT, PJ ;
MAH, DCW ;
WOODS, DE .
INFECTION AND IMMUNITY, 1994, 62 (05) :1914-1919
[7]   Structural and immunological characterization of Burkholderia pseudomallei O-polysaccharide-flagellin protein conjugates [J].
Brett, PJ ;
Woods, DE .
INFECTION AND IMMUNITY, 1996, 64 (07) :2824-2828
[8]  
Bryan L E, 1994, Can J Infect Dis, V5, P170
[9]   Antilipopolysaccharide II: An antibody protective against fatal melioidosis [J].
Charuchaimontri, C ;
Suputtamongkol, Y ;
Nilakul, C ;
Chaowagul, V ;
Chetchotisakd, P ;
Lertpatanasuwun, N ;
Intaranongpai, S ;
Brett, PJ ;
Woods, DE .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (04) :813-818
[10]   Melioidosis: Epidemiology, pathophysiology, and management [J].
Cheng, AC ;
Currie, BJ .
CLINICAL MICROBIOLOGY REVIEWS, 2005, 18 (02) :383-+